Pharma BD Deal Intelligence

GlaxoSmithKline plc / Novartis Consumer Healthcare JV

2018 · Asset Purchase · $13.0B · Complete

Announcement Sentiment

Positive

Outcome Score

Largely worked — most objectives met.

GSK acquired Novartis's 36.5% stake in consumer healthcare JV for $13B.

Key facts

Announced Mar 27, 2018
Closed Jun 01, 2018
Deal value $13.0B
Deal type Asset Purchase
Key assets Sensodyne','Panadol','Nicotinell and other consumer healthcare OTC brands